A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum
Research committees
Treatment
Eligibility Criteria Expand/Collapse
Please contact the CTSU directly by phone (888/823-5923) or on the CTSU website (http://www.ctsu.org/) for more information and registration procedures.
Publication Information Expand/Collapse
2024
2023
PMid: PMID36067452 | PMC number: PMC9870237
PMid: PMID35904874 | PMC number: PMC9691576
Transcriptional Profiling and Consensus Molecular Subtype Assignment to Understand Response and Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Colorectal Cancer
2022
PMid: PMID34528705
PMid: PMID35176136 | PMC number: PMC9093780
PMid: PMID36117191 | PMC number: PMC9482920
PMid: PMID34728807 | PMC number: PMC8738154
PMid: PMID35105521 | PMC number: PMC9058225
2021
PMid: PMID32958699 | PMC number: PMC7785628
PMid: PMID34374082 | PMC number: PMC8478698
PMid: PMID34636852
PMid: PMID34965954
Clinical trials as a path toward equity [Editorial]
PMid: PMID34374076
2020
Diabetes and Clinical Outcome in Patients with Metastatic Colorectal Cancer: CALGB 80405 (Alliance)
PMid: PMID32259016 | PMC number: PMC7043296
PMid: PMID33426464 | PMC number: PMC7785047
Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer
PMid: PMID32940631 | PMC number: PMC7499248
PMid: PMID33125497 | PMC number: PMC7599454
2019
PMid: PMID31548349 | PMC number: PMC6911644
PMid: PMID30865548 | PMC number: PMC6506418
PMid: PMID31042420 | PMC number: PMC6675593
Diet quality and survival in metastatic colorectal cancer (CRC): data from CALGB/SWOG 80405 (Alliance)
PMid: PMID31408415 | PMC number: PMC6900834
2018
PMid: PMID29871907 | PMC number: PMC6168379
2017
PMid: PMID28632865 | PMC number: PMC5545896
2016
2015
2014
2013
PMid: PMID23317558 | PMC number: PMC3790266
2007
Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 trial: a phase II trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarinoma
PMid: PMID17553204
2005
Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma PMID16356309